Mercy Rockford Health System issued the following announcement on May 17.
Dr. Sonya Ephraim, urogynecologist at Mercyhealth, was recently published for her research on using Botox to treat an overactive bladder.
Dr. Ephraim, along with six other researchers, were published in International Urology and Nephrology for their paper on “Outcomes of a single trigone-only vs. 20 trigone-sparing injections of OnabotulinumtoxinA for refractory overactive bladder (OAB).” International Urology and Nephrology publishes original papers on a broad range of topics in urology, nephrology and andrology.
Dr. Ephraim’s work compared the safety and durability of a single dose of Botox inserted into the bladder versus 20 Botox injections to treat a refractory overactive bladder. The Botox serves as a neuro-muscular blocker and can treat a refractory overactive bladder, a condition in which a patient has tried one or two medications for urgency and urgency leakage but does not notice improvement.
Their findings concluded that a single Botox injection appeared to be as safe and durable as multiple injections.
Sonya Ephraim, MD, FACOG, FPMRS, is a board certified female pelvic medicine and reconstructive surgeon at Mercyhealth Women’s Center. She earned her medical degree at the University of Buffalo School of Medicine and Biomedical Science, Buffalo, NY, and completed her Obstetrics and Gynecology residency at Rush University Medical Center, Chicago, IL. She is certified in the American Board of Obstetrics and Gynecology with added certification in Female Pelvic Medicine and Reconstructive Surgery.
Dr. Ephraim believes strongly in patient education and strives to make the patient feel at ease by listening to their concerns and alleviating fear by engaging them in the treatment process. She loves the opportunity to care for women and her goal is to make them feel as comfortable as possible through education.
Original source can be found here.
Alerts Sign-up